Treatment with nanosomal paclitaxel lipid suspension versus conventional paclitaxel in metastatic breast cancer patients - a multicenter, randomized, comparative, phase II/III clinical study.
Satheesh CT, Taran R, Singh JK, Shrivastav SP, Vithalani NK, Mukherjee KK, Nagarkar RV, Maksud T, Mehta AO, Srinivasan K, Vikranth M, Sonawane SR, Ahmad A, Sheikh S, Ali SM, Patel R, Paithankar M, Patel L, Rajani A, Bunger D, Chaturvedi A, Ahmad I.
Satheesh CT, et al. Among authors: srinivasan k.
Ther Adv Med Oncol. 2024 Apr 25;16:17588359241236442. doi: 10.1177/17588359241236442. eCollection 2024.
Ther Adv Med Oncol. 2024.
PMID: 38680290
Free PMC article.